interest-bearing debt to equity ratio increased from 1.5 times as of December 31, 2018 to 1.6 times as of September 30, 2019. FINANCIAL POSITION STATEMENT OF FINANCIAL POSITION ABBREVIATION & OUR
, net interest-bearing debt to equity ratio decreased from 1.5 times as of December 31, 2018 to 1.0 times as of December 31, 2019. FINANCIAL POSITION STATEMENT OF FINANCIAL POSITION ABBREVIATION & OUR
% Core EBITDA/ton ($) 102 113 140 (27%) 128 120 7% Operating Cash Flow5 261 250 241 8% 1,010 872 16% Net Debt to Equity (times) 0.92 0.87 0.61 51% 0.92 0.61 51% 1Consolidated financials are based upon
)% 4.12 3.26 26% Core EBITDA/ton ($) 102 113 140 (27%) 128 120 7% Operating Cash Flow5 261 250 241 8% 1,010 872 16% Net Debt to Equity (times) 0.92 0.87 0.61 51% 0.92 0.61 51% 1Consolidated financials are
the period. • As a result of the foregoing, net interest-bearing debt to equity ratio increased from 1.5 times as of December 31, 2018 to 1.6 times as of March 31, 2019. FINANCIAL POSITION STATEMENT OF
a result of the foregoing, net interest-bearing debt to equity ratio increased from 1.5 times as of December 31, 2018 to 1.6 times as of June 30, 2019. FINANCIAL POSITION STATEMENT OF FINANCIAL
interest bearing debt to equity of 0.75 times, compared to the Company’s policy of not exceeding 1.50 times and the debenture covenant of not exceeding 1.75 times. 2019 Outlook For 1H19, the overall
September 30, 2018, the Company’ s interest-bearing debt to equity ratio was merely 0.002 times, and its debt to equity ratio was 0.04 times. Please be informed accordingly. Very truly yours, Supamas
0.002 times, and its debt to equity ratio was 0.04 times. Please be informed accordingly. Very truly yours, Supamas Isarabhakdi Chief Executive Officer บริษัท ดีโอดี ไบโอเทค จ ำกัด (มหำชน) 111 หมู่ท่ี 2 ต